African Trypanosomiasis

African trypanosomiasis, commonly known as sleeping sickness, is a neglected tropical disease caused by protozoan parasites transmitted through the bite of infected tsetse flies. This condition remains a significant public health challenge in sub-Saharan regions, affecting vulnerable populations with limited access to healthcare services. African Trypanosomiasis continues to demand global attention due to its complex transmission dynamics, diagnostic challenges, and potential for severe neurological complications if untreated. This session at the Infectious Diseases Conference highlights advancements in surveillance, treatment, and elimination strategies aimed at reducing disease burden.

The disease manifests in two stages, beginning with hemolymphatic involvement and progressing to neurological impairment, leading to sleep disturbances, behavioral changes, and eventually fatal outcomes if not managed promptly. Early detection remains a challenge due to non-specific symptoms and limited diagnostic infrastructure in endemic areas. Therefore, strengthening community-level screening and improving laboratory capacity are critical priorities. In addition, vector control strategies targeting tsetse fly populations play a vital role in interrupting transmission cycles.

Recent developments in therapeutics, including safer and more effective oral treatments, have transformed disease management and improved patient outcomes. The integration of public health interventions, community engagement, and cross-border collaboration is essential for sustained elimination efforts. This session also connects with broader themes such as Neglected Infectious Diseases, emphasizing the need for equitable healthcare access and sustained funding. By addressing epidemiology, diagnostics, and control measures, this session provides a comprehensive platform for researchers and healthcare professionals to collaborate on innovative solutions to combat African trypanosomiasis globally.